Solitary Metastatic Renal Tumor from Breast Cancer.
10.4111/kju.2006.47.6.670
- Author:
Jae Sang JOO
1
;
Chang Min IM
;
Jeong Seon LEE
;
Kyung Jin OH
;
Taek Won KANG
;
Dong Deuk KWON
;
Kwangsung PARK
;
Soo Bang RYU
Author Information
1. Department of Urology, Chonnam National University Medical School, Gwangju, Korea. urokwon@gmail.com
- Publication Type:Case Report
- Keywords:
Kidney neoplasms;
Breast cancer;
Neoplasm metastasis
- MeSH:
Abdomen;
Breast Neoplasms*;
Breast*;
Drug Therapy;
Drug Therapy, Combination;
Epirubicin;
Female;
Follow-Up Studies;
Humans;
Kidney;
Kidney Neoplasms;
Lymph Nodes;
Mastectomy, Modified Radical;
Middle Aged;
Neoplasm Metastasis;
Nephrectomy;
Recurrence;
Ultrasonography
- From:Korean Journal of Urology
2006;47(6):670-673
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
We report a case of a metastatic renal tumor secondary to breast cancer 9 years postmastectomy. This is the first case report of solitary renal metastasis from breast cancer with no other evidence of metastasis. A 47-year-old woman underwent a modified radical mastectomy and 6 cycles of CEF chemotherapy (Cyclophosphamide, Epirubicin, 5-FU) for cancer of the left breast. She was followed closely, but no recurrence or metastases were detected on either a physical or radiological examination. 9 years later, on a routine follow-up examination for metastatic breast cancer, abdomen ultrasound revealed a solid mass (4cm in diameter) in the upper portion of the right kidney. Computed tomography (CT) was used to further evaluate the solitary renal mass, which had become moderately enhanced. No regional lymph node, visceral or pulmonary metastases were found. A radionuclide bone scan confirmed no bony involvement. A laparoscopic radical nephrectomy was performed for a right renal tumor. The histopathological features were identical to those for cancer of the right breast. The patient was treated with adjuvant combination chemotherapy (docetaxel and adriamycin), and is still alive 9 months after a right radical nephrectomy, with no evidence of recurrence.
